Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL201962 | 0.84 | LMNA (0.53) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL202539 | 0.82 | LMNA (0.52) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL3973273 | 0.78 | LMNA (0.47) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL20819062 | 0.77 | LMNA (0.50) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL203317 | 0.77 | TSHR (0.58) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL7070049 | 0.77 | TSHR (0.58) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL1759366 | 0.77 | TSHR (0.58) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL10912072 | 0.77 | LMNA (0.46) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL10733991 | 0.76 | LMNA (0.61) | LMNATSHRF2ALDH1A1TDP1 | |
| SCHEMBL9038964 | 0.76 | ALDH1A1 (0.40) | LMNATSHRALDH1A1MAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410357-A | Multi-element external electron donor composition and application thereof | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | claimed |
| US-12434998-B2 | Resin-coated ultra-thin glass | TORAY INDUSTRIES, INC. (JP) | 2025-10-07 | — | — | US | disclosed |
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-02-27 | — | — | US | disclosed |
| US-20230365458-A1 | RESIN-COATED ULTRA-THIN GLASS | TORAY INDUSTRIES, INC. (JP) | 2023-11-16 | — | — | US | disclosed |
| CN-110573964-B | Negative photosensitive resin composition and cured film | 东丽株式会社 | 2023-11-03 | — | — | CN | disclosed |
| CN-116410357-A | Multi-element external electron donor composition and application thereof | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-101226329-B | Radiation sensitive resin composition, laminated insulating film, micro lens and preparation method thereof | JSR CORP | 2012-09-05 | — | — | CN | disclosed |
| CN-100554315-C | Organopolysiloxane and contain the solidification compound of organopolysiloxane | TOAGOSEI CO LTD (JP) | 2009-10-28 | — | — | CN | disclosed |
| US-7576142-B2 | Polyorganosiloxane and curable composition containing same | TOAGOSEI CO., LTD. (JP) | 2009-08-18 | — | — | US | disclosed |
| EP-1775317-B1 | POLYORGANOSILOXANE AND CURABLE COMPOSITION CONTAINING SAME | TOAGOSEI CO LTD (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-20080033137-A1 | Polyorganosiloxane And Curable Composition Containing Same | TOAGOSEI CO., LTD. (JP) | 2008-02-07 | — | — | US | disclosed |
| CN-1965016-A | Polyorganosiloxane and curable composition containing same | TOAGOSEI CO LTD (JP) | 2007-05-16 | — | — | CN | disclosed |
| EP-1775317-A1 | POLYORGANOSILOXANE AND CURABLE COMPOSITION CONTAINING SAME | TOAGOSEI CO., LTD. (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-20070055034-A1 | Process for producing cation-curable silicon compound | TOAGOSEI CO., LTD. (JP) | 2007-03-08 | — | — | US | disclosed |
| CN-1753936-A | Process for producing cation-curable silicon compound | TOAGOSEI CO LTD (JP) | 2006-03-29 | — | — | CN | disclosed |
| EP-1598389-A1 | PROCESS FOR PRODUCING CATION-CURABLE SILICON COMPOUND | TOAGOSEI CO., LTD. (JP) | 2005-11-23 | — | — | EP | disclosed |
| EP-0564004-B1 | A highly stereoregular polypropylene | CHISSO CORP (JP) | 1996-09-25 | — | — | EP | disclosed |
| EP-0564004-A1 | A highly stereoregular polypropylene | CHISSO CORPORATION (JP) | 1993-10-06 | — | — | EP | disclosed |
| US-5077341-A | Using coordination catalyst | CHISSO CORPORATION (JP) | 1991-12-31 | — | — | US | disclosed |
| EP-0404519-A2 | A process for producing a high-stiffness polypropylene | CHISSO CORPORATION (JP) | 1990-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912731-B2 | Use of silylated formiates as hydrosilane equivalents | PFAS, EPM2A, CYP2F1 | LMNA 400/4885TSHR 3111/4885F2 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.